Stefan James
Latest contributions
SWEDEHEART: Improving the quality of cardiology care in Sweden and beyond!
22 May 2025
Lars Wallentin and Stefan James received the Andreas Grüntzig Ethica Award during EuroPCR 2025, on behalf of a wider team of cardiovascular registry experts who have contributed in an extraordinary way to the PCR mission.
2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James on behalf of Swedish cardiovascular registry experts
20 May 2025
The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.
Worldwide experiences on contemporary TAVI implantation technique with Evolut platform
17 May 2022 – From EuroPCR 2022
Through this discussion between Yohei Ohno, Kendra Grubb, and Stefan James recorded for EuroPCR 2022, discover recent updates on the COT experience/studies (optimize PRO 400pts, OCEAN TAVI, personal experience), find out about key success factors/steps on the technique to achieve optimal results, and learn how to...
Complex PCI in high bleeding risk patients
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to identify high bleeding risk (HBR) patients requiring adjusted antithrombotic strategy and how to tailor PCI strategies to specific HBR patient for drug-device synergy.
Contemporary strategies for challenging diseases: optimising treatments with ultrathin strut DES
22 May 2019 – From EuroPCR 2019
Consult this session on ultrathin strut drug-eluting stent to learn more about its role in treating complex lesions and patient types, and to discover contemporary approaches to manage various challenging cases, such as ACS STEMI, CTO, and more!
Optimising the generation and regulatory application of clinical evidence in the European Union and the United States
22 May 2019 – From EuroPCR 2019
Consult this session to discover innovative approaches for collecting and utilising clinical evidence, and learn more about how to conduct efficient clinical research to support marketing approval in the European Union, the United States, or regions dependent on the CE mark or FDA approval.
Cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease, and the clinical strategy for treatment implementation.
Mechanical circulatory support for protected high-risk PCI: when and how?
21 May 2019 – From EuroPCR 2019
Consult this session on high-risk PCI to learn all about the risks and benefits of mechanical circulatory support, with various clinical cases demonstrating when and how to use it, and how to select the appropriate patient to undergo this procedure.
Andreas Grüntzig Ethica Awardees
19 Jul 2017
Discover the list of all the Andreas Grüntzig Ethica Awardees.
